PubMed Health⌕ Search

PubMed · 3480678

Prognosis in soft tissue sarcoma.

Abstract

Consensus is still lacking as regards which surgical procedures carry a low risk of local recurrence in soft tissue sarcoma. A series of 81 patients with Grades I-IV soft tissue sarcomas of the locomotor system, with a minimum follow-up time of 6 years, was studied with respect to local recurrence. All the patients were operated on with wide surgical margins without adjunctive therapy. A subclassification of these margins was performed. A wide F margin, obtained by myectomy of one or several muscles, but not of the total compartment, was found to be a safe procedure, giving a local recurrence rate of less than 0.1. This applied when surgery was performed without a preceding open biopsy. For subcutaneous tumors a wide S margin, including the deep fascia, also resulted in a small local recurrence rate, even if performed after incisional biopsy or marginal surgery. More than one half of all patients with soft tissue sarcoma in the locomotor system have tumors suitable for surgical treatment with a wide F or a wide S margin for a low local recurrence risk. A wide margin where the surgical dissection had transgressed the muscle where the tumor was located or areolar tissue in cases of extramuscular tumor (wide AM margin) was found to result in a higher local recurrence rate, around 0.25. There is no generally accepted staging system for soft tissue sarcomas. Those systems in most common use were not constructed after statistical multivariate analysis, whereby the strongest prognostic factors may be identified. The staging system of the American Joint Committee (AJC), the system of Hajdu, and the Surgical Staging System (SSS) were evaluated with respect to their ability to discriminate patients with different chances for survival in a series of 122 patients operated on with wide or radical surgical margins. None of the three systems could identify patient-groups with a significantly different prognosis better than that, that could simply be done by the histologic malignancy grading of the tumors. A multivariate analysis of variables thought to be of prognostic significance for local recurrence and survival was performed in a series of 144 patients with Grades III and IV soft tissue sarcomas. Marginal surgery, extracompartmental tumor location, and tumor necrosis increased the risk of local recurrence. Local recurrence, male sex, malignancy grade IV, tumor necrosis, and increasing tumor size increased the risk of tumor-related death.(ABSTRACT TRUNCATED AT 400 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

B Rööser. 1987. Prognosis in soft tissue sarcoma.. https://doi.org/10.3109/17453678709154498

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Fibromyalgia. Diagnostics--disease approach--therapy].

Fibromyalgia is a complex of symptoms predominantly affecting females and consisting of widespread pain. Etiology and pathogenesis are not sufficiently known yet, however, there is the assumption that fibromyalgia is looked at as being an illness with biological, psychological, and social aspects. Therefore, the treatment of fibromyalgia calls for a multimodal therapy approach. The importance of fibromyalgia has been recognized within the German health system by creating the new ICD code M79.70 and by assigning fibromyalgia its own rheumatologic DRG (I79Z). In future research of fibromyalgia special attention needs to be placed upon gender-specific problems.

Combined Modality Therapy↗

Lack of survival benefit of post-operative radiation therapy in prostate cancer patients with positive lymph nodes.

Randomized data from SWOG 8794 and EORTC 22911 confirm the benefit of post-operative radiation therapy (RT) for selected patients with pT3 prostate cancer (CaP) after radical prostatectomy (RP). However, data regarding the potential benefit of RT for patients post-RP with positive lymph node (+LN) involvement are limited. We analyzed the Surveillance Epidemiology End Results (SEER) registry for population-based data on efficacy of post-operative RT for +LN patients after RP. As LN data have only been captured by SEER since 1988, we analyzed data for 1988-1992, with specific attention to 10-year relative survival (defined as observed survival divided by the survival of a gender-, age- and race-matched population cohort without disease). Specifically analyzed were data for 1921 patients with nonmetastatic prostate cancer who underwent surgery alone, or surgery followed by RT, and who had +LNs documented. SEER does not code the interval between surgery and RT, so the ratio of patients receiving salvage versus adjuvant therapy is unknown. Using follow-up data through 2002, post-diagnosis survival was examined by number of +LNs. There was no significant relative survival benefit for +LN patients receiving post-operative RT (chi(2)P=0.270). These data do not support routine use of post-operative RT for patients with +LNs in the surgical specimen.

Combined Modality Therapy↗